Singapore, June 3 -- Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive solutions that span all stages of therapeutic development from discovery through to commercialization, has announced new names and identities as part of a strategic positioning effort.

The Group Companies' new names, collaborative strategic focus, and structural alignment reflects Fujifilm's commitment to Life Sciences, offering fully integrated, end-to-end solutions across the drug development lifecycle-from research and discovery to clinical and commercial manufacturing.

Fujifilm Irvine Scientific becomes Fujifilm Biosciences, providing a full spectrum of life sciences s...